Answers are grounded in this paper and cite their sources.
Summary: The identification of novel, oncogenic gene rearrangements in inflammatory myofibroblastic tumor demonstrates the potential of next-generation sequencing (NGS) platforms for the detection of therapeutically relevant oncogenes across multiple tumor types, but raises significant questions relating to the investigation of targeted therapies in this new era of widespread NGS testing. Cancer Discov; 4(8); 870–2.
No takes yet. Share an insight, caveat, or question.
Le et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: